ArticlePloS one2017

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.

Teresa Magnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.